Medpace Holdings (MEDP) Tops Q3 EPS by 33c, provides guidance
Medpace Holdings (NASDAQ: MEDP) reported Q3 EPS of $3.86, $0.33 better than the analyst estimate of $3.53. Revenue for the quarter came in at $659.9 million versus the consensus estimate of $640.99 million.
GUIDANCE:
Medpace Holdings sees FY2025 revenue of $2.48-2.53 billion, versus the consensus of $2.465 billion.
For earnings history and earnings-related data on Medpace Holdings (MEDP) click here.
